Rubicon Research Limited header image

Rubicon Research Limited

544578

Equity

ISIN INE506V01022 / Valor 149582844

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-01)

INR 1,367.30-2.44%

Rubicon Research Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Rubicon Research Limited is an integrated specialty pharmaceutical company, incorporated in 1999 and headquartered in Mumbai (Thane). The company focuses on the research, development and manufacturing of specialty and generic prescription products primarily for the US regulated market, with proprietary drug delivery platforms including RubiSRL (sustained release liquids) and RubiReten (gastro-retentive systems). Its therapeutic portfolio spans analgesics, gastrointestinal, cardiovascular, CNS, nicotine replacement therapy and immunosuppressant products. Rubicon listed on BSE and NSE following its 2024 IPO.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

%1Y

%3Y

%5Y

Performance

45.6%1Y

45.6%3Y

45.6%5Y

Volatility

2367 M

Market cap (USD)

12,435

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

MedPlus Health Services Ltd.

MedPlus Health Services Ltd. Valor: 115381597

Annual Return

-50%0%+50%

Risk level

110

0.56%INR 815.60

Global Health Limited

Global Health Limited Valor: 122795249

Annual Return

-50%0%+50%

Risk level

110

0.99%INR 1,327.60

Mankind Pharma Ltd.

Mankind Pharma Ltd. Valor: 126566338

Annual Return

-50%0%+50%

Risk level

110

-2.21%INR 2,490.20

Tilray Brands Inc

Tilray Brands Inc Valor: 42386407

Annual Return

-50%0%+50%

Risk level

110

-1.34%USD 4.43

Centene Corp

Centene Corp Valor: 1313733

Annual Return

-50%0%+50%

Risk level

110

6.48%USD 68.35

Inventiva SA

Inventiva SA Valor: 35598121

Annual Return

-50%0%+50%

Risk level

110

-1.40%EUR 3.17

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited Valor: 136422285

Annual Return

-50%0%+50%

Risk level

110

-0.33%INR 1,829.75

SAI Life Sciences Ltd.

SAI Life Sciences Ltd. Valor: 140605954

Annual Return

-50%0%+50%

Risk level

110

0.67%INR 1,242.90

Dynavox Group AB

Dynavox Group AB Valor: 114900704

Annual Return

-50%0%+50%

Risk level

110

3.59%SEK 60.55

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited Valor: 30691066

Annual Return

-50%0%+50%

Risk level

110

-1.51%INR 1,622.25

SIX

FactSet

Clearbit

Logos provided by Clearbit